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Bcl-2-like protein 13 is a mammalian Atg32
homologue that mediates mitophagy and
mitochondrial fragmentation
Tomokazu Murakawa1, Osamu Yamaguchi1, Ayako Hashimoto2, Shungo Hikoso1, Toshihiro Takeda1,
Takafumi Oka1, Hiroki Yasui1, Hiromichi Ueda1, Yasuhiro Akazawa1, Hiroyuki Nakayama3, Manabu Taneike4,
Tomofumi Misaka4, Shigemiki Omiya4, Ajay M. Shah4, Akitsugu Yamamoto5, Kazuhiko Nishida4,
Yoshinori Ohsumi6, Koji Okamoto2, Yasushi Sakata1 & Kinya Otsu4
Damaged mitochondria are removed by mitophagy. Although Atg32 is essential for
mitophagy in yeast, no Atg32 homologue has been identiﬁed in mammalian cells. Here,
we show that Bcl-2-like protein 13 (Bcl2-L-13) induces mitochondrial fragmentation and
mitophagy in mammalian cells. First, we hypothesized that unidentiﬁed mammalian
mitophagy receptors would share molecular features of Atg32. By screening the public
protein database for Atg32 homologues, we identify Bcl2-L-13. Bcl2-L-13 binds to LC3 through
the WXXI motif and induces mitochondrial fragmentation and mitophagy in HEK293 cells. In
Bcl2-L-13, the BH domains are important for the fragmentation, while the WXXI motif
facilitates mitophagy. Bcl2-L-13 induces mitochondrial fragmentation in the absence of Drp1,
while it induces mitophagy in Parkin-deﬁcient cells. Knockdown of Bcl2-L-13 attenuates
mitochondrial damage-induced fragmentation and mitophagy. Bcl2-L-13 induces mitophagy in
Atg32-deﬁcient yeast cells. Induction and/or phosphorylation of Bcl2-L-13 may regulate its
activity. Our ﬁndings offer insights into mitochondrial quality control in mammalian cells.
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M
itochondria are subcellular organelles that produce
energy through oxidative phosphorylation. Dysregu-
lated mitochondrial activity results in generation
of reactive oxygen species as a by-product of oxidative
phosphorylation, which cause damage to DNA and proteins1.
Thus, mitochondrial quality control is essential for normal
cellular functions. Macroautophagy (hereafter referred to
autophagy) is responsible for mitochondrial quality control1.
There are two types of autophagy, non-selective and selective
autophagy. Non-selective autophagy sequesters bulk cytoplasm
and organelles engulfed by isolation membrane as cargos to
autophagosomes2. These then undergo fusion with lysosomes,
allowing degradation of the cargo. In contrast, selective
autophagy targets speciﬁc proteins or organelles as cargos, such
as mitochondria and peroxisomes. The degradation of damaged
mitochondria is mediated by a selective type of autophagy,
mitophagy3. Dysregulation of mitophagy is implicated in the
development of neurodegenerative diseases, such as Alzheimer’s
disease and Parkinson’s disease as well as metabolic diseases,
heart failure and ageing3.
Mitochondrial morphologies change continuously through
actions of ﬁssion and fusion (collectively termed mitochondrial
dynamics). In yeast4 and mammalian cells5, mitophagy is reported
to be preceded by mitochondrial ﬁssion, which divides elongated
mitochondria into pieces of manageable size for engulfment by
isolation membrane. To date, more than 30 autophagy-related (Atg)
genes have been identiﬁed, which function as molecular machinery
for autophagy2. In yeast, Atg32 is essential for mitophagy and
functions as a receptor of mitophagy through its interaction with
Atg8 and Atg11 (ref. 6,7). It has a single transmembrane domain in
the C-terminal ﬁfth of the protein, spanning outer mitochondrial
membrane (OMM) and contains a WXXI motif, which binds to
Atg8. Based on amino acid similarity, Atg32 has no mammalian
homologue.
In mammals, mitophagy is involved in mitochondria
elimination from reticulocytes, which is mediated by NIP3-like
protein X (NIX, also known as BNIP3L)8. It is also reported that
FUNDC1, localized in OMM, is a receptor for hypoxia-induced
mitophagy9. The OMM kinase, phosphatase and tensin homolog
(PTEN)-induced putative kinase protein 1 (PINK1) and the
cytosolic E3 ubiquitin ligase Parkin, the mutations of which are
causative for hereditary Parkinson’s disease, are known to
mediate mitophagy to eliminate damaged mitochondria in
many types of cells10. Parkin is expressed in most of adult
tissues, but some fetal tissues and cell lines including HeLa cells
show little or no endogenous Parkin expression11–13. Parkin-
deﬁcient mice show only mild phenotypes14. Thus, it is
reasonable to assume that there may be an unknown receptor
for mitophagy in mammalian cells. Here, we show that Bcl2-L-13
induces mitochondrial fragmentation and mitophagy in
mammalian cells and can function as a mitophagy receptor
when it is expressed in yeast.
Results
Identiﬁcation of Bcl2-L-13. In this study, we hypothesized that a
mammalian mitophagy receptor will share the following mole-
cular features with Atg32: mitochondrial localization; WXXL/I
motifs; acidic amino acid clusters; and single membrane-spanning
topology. Using this molecular proﬁle of Atg32 as a search tool,
we screened UniProt database (http://www.uniprot.org/) for
novel Atg32 functional homologues and identiﬁed Bcl-2-like
protein 13 (Bcl2-L-13).
Mouse Bcl2-L-13 gene (Bcl2l13) encodes a protein of 434
amino acids, which contains a C-terminal single transmembrane
domain15 (Fig. 1a). Bcl2-L-13 is expressed in all tissues and cell
lines tested including HeLa cells and localized in mitochondria.
It has been known that Bcl2-L-13 contains four conserved Bcl-2
homology domains (BH1-4) and triggers cell death independently
of the BH domains. In contrast to the previous report,
overexpression of Bcl2-L-13 did not induce the activation of
caspase 3 in HEK293 cells (Fig. 1b). Sequence alignment of mouse
Bcl2-L-13 revealed 2 WXXL/I motifs at positions 147–150 and
273–276 (Fig. 1a,c).
Bcl2-L-13 binds to LC3. To examine the interaction of Bcl2-L-13
with LC3, a mammalian homologue of Atg8, a yeast two-hybrid
assay was performed between Gal4-fused LC3B and activation
domain-fused Bcl2-L-13. The cells expressing LC3B and wild-
type Bcl2-L-13 could grow on selective plates (Fig. 1d). We
generated Bcl2-L-13 mutants containing amino acid substitution
in the WXXL/I motifs and found that Bcl2-L-13 W273A I276A or
W147A L150A/W273A I276A, but not W147A L150A had a
reduced interaction with LC3B. Consistent with the yeast two-
hybrid results, puriﬁed glutathione S-transferase (GST)-LC3B
could pull down wild-type Bcl2-L-13 overexpressed in HEK293
cells, but Bcl2-L-13 W273A I276A showed decreased binding
with LC3 (Fig. 1e), suggesting the second WXXL/I motif at
residues 273–276 is a functional LC3-interacting region (LIR)16
(Fig. 1c). The mitochondrial uncoupler carbonyl cyanide
m-chlorophenylhydrazone (CCCP) has been used to induce
mitochondrial damage and mitophagy17. CCCP treatment
increased the interaction of endogenous Bcl2-L-13 with LC3 in
HEK293 cells (Fig. 1f).
Bcl2-L-13 is an outer mitochondrial membrane protein.
To conﬁrm that Bcl2-L-13 is an integral mitochondrial mem-
brane protein, the mitochondrial fraction from HEK293 cells was
treated with Na2CO3, which results in release of soluble and
peripheral proteins18,19 (Fig. 1g). Bcl2-L-13, the outer-membrane
protein, Tom20 and the inner-membrane protein, Tim23 were
retained in the pellet, whereas cytochrome c was released to the
supernatant, suggesting Bcl2-L-13 is an integral mitochondrial
membrane protein. Treatment of mitochondrial fraction with
proteinase K resulted in almost complete digestion of Bcl2-L-13
and Tom20, but a signiﬁcant amount of Tim23 remained
(Fig. 1h). These results indicate that Bcl2-L-13 is an integral
OMM protein. Since the anti-Bcl2-L-13 antibody used in this
study recognizes amino acids near the centre of Bcl2-L-13,
Bcl2-L-13 has its N-terminus exposed to the cytosol and
C-terminus in the intermembrane space.
Bcl2-L-13 induces mitochondrial fragmentation. To identify
functions of Bcl2-L-13, HA-Bcl2-L-13 was exogenously
introduced into HEK293 cells or knockdown of endogenous
Bcl2-L-13 was performed using small interfering RNA (siRNA)
(Fig. 2a,b). HA-Bcl2-L-13 overexpression induced mitochondrial
fragmentation (Fig. 2c,d). Bcl2-L-13-induced fragmented mito-
chondria were seen as numerous small sphere-like structures.
Intra-mitochondrial density increased, but their cristae structure
appeared to be maintained. The Bcl2-L-13 siRNA decreased the
endogenous protein level (Fig. 2b), which induced mitochondrial
elongation (Fig. 2e,f), indicating that endogenous Bcl2-L-13 is
required for mitochondrial ﬁssion. The mitochondrial potential
estimated by tetramethylrhodamine ethyl ester (TMRE) was
maintained in the fragmented mitochondria (Fig. 2g).
We examined the roles of the WXXL/I motifs, transmembrane
region and BH domains in Bcl2-L-13-induced mitochondrial
fragmentation. Overexpression of WXXL/I mutants containing
W147A L150A or W273A I276A substitution induced mitochon-
drial fragmentation (Figs 2a and 3a,b). The Bcl2-L-13 lacking the
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transmembrane domain showed diffuse cytoplasmic expression
pattern without mitochondrial fragmentation (Fig. 3c). Thus,
mitochondrial localization but not LC3 binding is required for
Bcl2-L-13-induced fragmentation. A deletion mutant for BH4
(DN(1–32)), BH1 (D142–154) or BH2 (D192–228) domain or an
amino acid mutant in BH3 (L101E) or BH4 (V19G) did not
induce mitochondrial fragmentation (Fig. 3a,d,e). The point
mutations (L101E and V19G) had no effect on apoptosis
(Fig. 1b). Thus, all BH1-4 domains are important for
Bcl2-L-13-induced fragmentation.
The relationship between Bcl2-L-13 and Drp1. Dynamin-
related protein 1 (Drp1) is known to be the master regulator
of mitochondrial ﬁssion1. Mitochondrial ﬁssion 1 (Fis1) is a
partner protein of Drp1. On the other hand, mitofusins, Mfn1
and Mfn2, together with optic atrophy protein 1 (Opa1) are the
core components of the mitochondrial fusion machinery.
Knockdown of Drp1 resulted in elongation of mitochondria
and overexpression of HA-Bcl2-L-13 was still able to induce
mitochondrial fragmentation in Drp1 knockdown cells
(Fig. 4a–c). However, the ratio of cells with fragmented
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Figure 1 | Molecular characteristics of Bcl2-L-13. (a) Schematic representation of mouse Bcl2-L-13 domain structure. The predicted BH1-4 domains,
WXXL/I motifs and transmembrane domain (TMD) are indicated. (b) Bcl2-L-13 failed to induce apoptosis in HEK293A cells. Western blot analysis of
cleaved caspase 3 in whole-cell lysates from cells expressing the indicated HA-tagged Bcl2-L-13 constructs. Cell lysates with 100mM etoposide treatment
for 24 h were shown as a positive control. (c) Sequence alignment of the WXXL/I motif in Atg32, human and mouse Bcl2-L-13, and human FUNDC1 and
NBR1. (d) Yeast two-hybrid assay to examine the interaction between LC3B and wild-type or the indicated mutant HA-Bcl2-L-13. (e) HEK293A cells were
transfected with wild-type or mutant HA-Bcl2-L-13. Forty-eight h after transfection, cells were lysed and incubated with GST-LC3B. The co-precipitated
proteins with GST-LC3B were detected by immunoblotting for HA. Coomassie brilliant blue staining was performed to visualize GST or GST-LC3B. Right
panel represents densitometric analysis of the band for HA. The value for cells transfected with Bcl2-L-13 in each experiment was set equal to 1 (n¼ 3).
Results are shown as the mean±s.e.m. *Po0.05 versus all other groups. (f) HEK293A cells were treated with 5 mM CCCP and 20 nM baﬁlomycin A1 for
1 h. Then, cells were lysed and immunoprecipitated with anti-Bcl2-L-13 antibody. Co-precipitated LC3 were detected by immunoblotting. Right panel
represents densitometric analysis of the band for LC3. The value for cells treated with CCCP and immunoprecipitated with anti-Bcl2-L-13 antibody was set
equal to 1 (n¼ 3). Results are shown as the mean±s.e.m. *Po0.05 versus all other groups. (g) Mitochondrial fraction from HEK293A cells in the
mitochondrial buffer (Buffer) alone or in buffer containing Na2CO3 or Triton X-100. The pellets (P) and supernatant fractions (S) were immunoblotted with
the indicated antibodies. (h) Mitochondrial fraction was digested with proteinase K in the absence or presence of Triton X-100 and immunoblotted with the
indicated antibodies. A one-way ANOVA followed by Tukey–Kramer’s post hoc test was used for statistical analysis.
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mitochondria was reduced in Drp1 knockdown cells.
Phosphorylation of Drp1 on Ser637 inhibits mitochondrial
ﬁssion, while phosphorylation of that on Ser616 promotes
mitochondrial ﬁssion20. Overexpression of Bcl2-L-13 increased
the amount of phosphorylated Drp1 on Ser637 and decreased
that on Ser616 (Fig. 4d). On the other hand, knockdown of
Bcl2-L-13 increased the amount of phosphorylation on Ser616,
but not on Ser637, when compared with control siRNA cells.
Dimer formation of the dynamin-related proteins such as Drp1
increases their GTPase activity20. Overexpression of Bcl2-L-13 led
to a decrease in dimer formation of Drp1 (Fig. 4e). These data
suggest that Drp1 appeared to compensate Bcl2-L-13-induced
changes in mitochondrial morphology. Thus, Drp1 is not
essential for Bcl2-L-13-induced mitochondrial fragmentation.
Changes in Bcl2-L-13 expression had no effect on the protein
level of Fis1 or the molecules involved in fusion such as Mfn1,
Mfn2 and Opa1 (Fig. 4d,f). In addition, HA-Bcl2-L-13 was able to
induce mitochondrial fragmentation in Bak or Bax knockdown
cells (Fig. 4g,h).
Bcl2-L-13 induces mitophagy. Then, we investigated the role of
Bcl2-L-13 in mitophagy. Conversion of LC3-I to LC3-II is an
essential step for autophagosome formation21. HA-Bcl2-L-13
increased LC3-II protein level (left top blot and right upper panel
in Fig. 5a). To assess the autophagy ﬂux, we treated cells with a
lysosomal inhibitor, baﬁlomycin A1. Treatment with baﬁlomycin
A1 led to an increase in protein level of LC3-II. For quantitative
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Figure 2 | The function of Bcl2-L-13 in mitochondrial dynamics. (a,b) Expression level of Bcl2-L-13 mutants. Immunoblot of whole-cell lysates from
HEK293A cells expressing various HA-tagged Bcl2-L-13 constructs 48 h after transfection (a). HEK293A cells were transfected with Bcl2-L-13-speciﬁc
siRNA (siBcl2-L-13) or with a non-targeting control siRNA (siCTRL), and analysed by immunoblotting with anti-Bcl2-L-13 antibody (b). (c) Mitochondrial
morphology in HEK293A cells transfected with empty vector or HA-Bcl2-L-13 was analysed using anti-ATP synthase and anti-HA antibodies. Boxed areas
for ATP synthase staining are shown at higher magniﬁcation (high) in the right panels. Scale bar, 10mm. (d) Electron micrographs of mitochondria in
HEK293A cells transfected with empty vector or HA-Bcl2-L-13. Images at higher magniﬁcation are shown in the right panels. Scale bar, 1 mm in the left
panels and 200nm in the right panels. (e) Representative z-stack confocal images of mitochondrial morphologies in HEK293A cells transfected with
siCTRL or siBcl2-L-13 using anti-ATP synthase antibody. Scale bar, 10mm. (f) Electron micrographs of mitochondria in HEK293A cells transfected with
siCTRL or siBcl2-L-13. Images at higher magniﬁcation are shown in the right panels. Scale bar, 5 mm in the left panels and 2 mm in the right panels.
(g) HEK293A cells transfected with GFP-Bcl2-L-13 were strained with TMRE. Scale bar, 10mm.
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analysis, we exposed the transfer membrane to the ﬁlm for a
shorter period (the second blot from the top blot in Fig. 5a). The
level of LC3-II in HA-Bcl2-L-13 overexpressing cells was higher
than that in cells transfected with empty vector or Bcl2-L-13
W273A I276A after treatment with baﬁlomycin A1 (right lower
panel in Fig. 5a). This indicates that the increase in LC3-II level in
HA-Bcl2-L-13 overexpressing cells is not because of reduced
autophagosome turnover, but increased autophagic ﬂux. We
produced a stable cell line of HEK293 expressing mitochondrial
targeted Keima (mKeima), a coral-derived acid-stable lysosomal
proteases-resistant ﬂuorescent protein22. We used the excitation
of mKeima at 559 nm that causes emission when the molecule
is in acidic compartments such as lysosome as well as in neutral
compartments22 (Fig. 5b). We transfected the cells with HA-Bcl2-
L-13 and GFP-LC3 and incubated with protease inhibitors to
derive sufﬁcient number of autophagosomes or autolysosomes
for analysis. Bcl2-L-13 increased the number of LC3- and
mKeima-positive dots (Fig. 5c). Next, mKeima-expressing
HEK293 cells were transfected with HA-Bcl2-L-13 and stained
with LysoTracker Green before microscopic analysis (Fig. 5d,e).
HA-Bcl2-L-13 increased the number of LysoTracker- and
mKeima-positive dots. These results indicate that mitochondria
were engulfed in autophagosomes or autolysosomes. Ultra-
structural analysis of HA-Bcl2-L-13 expressing HEK293 cells
revealed double-membrane vacuoles containing a single
mitochondrion-like structure, but little cytoplasm (Fig. 5f).
HA-Bcl2-L-13 signiﬁcantly reduced mitochondrial DNA
amount (Fig. 5g). These indicate that Bcl2-L-13 induced
mitophagy. The mutations in the LIR domain reduced
mitophagic activity (Fig. 5a,c–g). The mutants in the BH
domains were unable to induce mitochondrial fragmentation
and subsequent mitophagy (Fig. 5d,e). Thus, Bcl2-L-13 induces
mitophagy through the interaction with LC3.
Bcl2-L-13 induces mitophagy in Parkin-independent manner.
To examine whether Bcl2-L-13-induced mitophagy is coupled to
the PINK1/Parkin-mediated pathway, we expressed HA-Bcl2-
L-13 in Parkin knockdown HEK293 cells harbouring mKeima.
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Bcl2-L-13 induced a similar level of mitophagy in Parkin
knockdown HEK293 and control cells, as indicated by the
number of LysoTracker- and mKeima-positive dots (Fig. 6a).
Furthermore, Bcl2-L-13 was able to induce mitophagy in HeLa
cells, which reportedly lack a functional Parkin gene12 (Fig. 6b).
It has been reported that the mitochondria were maintained
after adding CCCP in HeLa cells, whereas few mitochondria
remained detectable in Parkin expressing HeLa cells, assessed
by immunocytochemistry using anti-Tom20 antibody17. We
conﬁrmed the effect of Parkin on CCCP-treated HeLa cells
(Fig. 6c). Similar selective mitochondrial elimination by CCCP
treatment was observed in Bcl2-L-13 expressing HeLa cells. These
indicate that Parkin is not necessary for Bcl2-L-13 to induce
mitophagy.
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Bcl2-L-13 functions as a mitophagy receptor in yeast. Atg32 is
essential for mitophagy under respiratory conditions6,7. Yeast
cells expressing the mitochondrial matrix-targeted dehydrofolate
reductase-mCherry protein (mito-dihydrofolate reductase
(DHFR)-mCherry) were grown under respiratory conditions23.
It has been reported that mitophagy in yeast is strongly activated
in cells at stationary phase, which seems to be triggered by
oxidative stress6. Upon mitophagy, this fusion protein is
transported and processed to generate free mCherry in the
vacuole. In yeast lacking Atg32, the processing of mito-DHFR-
mCherry barely occurred. We replaced the transmembrane
domain in Bcl2-L-13 with mitochondrial tail-anchor (TAmito)
domain derived from an authentic outer membrane protein to
facilitate mitochondrial localization of the expressed protein in
yeast23. Surprisingly, expression of Bcl2-L-13 (1–407)-TAmito in
atg32D yeast generated free mCherry, suggesting partial
restoration of the ability to induce mitophagy, but the LIR
mutant did not (Fig. 7a). Furthermore, Bcl2-L-13 failed to induce
mitophagy in atg7D (Fig. 7b), suggesting Bcl2-L-13-induced
mitophagy is mediated through known autophagy molecular
machinery. These results indicate that Bcl2-L-13 can substitute
for Atg32 in yeast. To conﬁrm that Bcl2-L-13 induces mitophagy
in mammalian cells, we generated a fusion construct of
mCherry and Tom22 to target mCherry to mitochondria,
and transfected HEK293 cells with mCherry-Tom22 and wild-
type or the indicated mutant HA-Bcl2-L-13. Overexpression of
Bcl2-L-13 generated free mCherry in HEK293 cells (Fig. 7c).
The protein level of processed mCherry in cells transfected with
Bcl2-L-13 was more than that in Bcl2-L-13 W273A I276A
overexpressing cells.
The physiological signiﬁcance of Bcl2-L-13. We next investi-
gated the physiological signiﬁcance of endogenous Bcl2-L-13
in mitochondrial dynamics and mitophagy. CCCP induced
fragmentation of mitochondria in HEK293 cells (Fig. 8a,b) and
mitophagy in mKeima-expressing HEK293 cells (Fig. 8c).
Knockdown of Bcl2-L-13 attenuated CCCP-induced fragmenta-
tion and mitophagy, indicating that endogenous Bcl2-L-13 plays
an important role in CCCP-induced mitochondrial fragmentation
and mitophagy.
Then, we attempted to elucidate the activation mechanism of
Bcl2-L-13 to induce mitochondrial fragmentation and mitophagy.
Atg32 is temporally upregulated to induce mitophagy and
subsequently degraded6,7. The Atg11-Atg32 interaction is
believed to be the initial molecular step, in which the
autophagic machinery recognizes mitochondria as a cargo.
Phosphorylation of the Ser-114, close to Atg8-interaction site
(amino acid residue 86–89), in Atg32 mediates the Atg11–Atg32
interaction and mitophagy24,25. Thus, induction of the protein
and/or post-translational modiﬁcation of Bcl2-L-13 might
regulate its function. The protein level of Bcl2-L-13 was
increased 1 h after CCCP treatment compared with control,
then returned to baseline thereafter (Fig. 8d). Overexpression of
Bcl2-L-13 induced its Ser/Thr phosphorylation (Fig. 8e). We
mutated Ser272 to Ala in Bcl2-L-13, which is close to the second
LIR motif. The phosphorylation level of Bcl2-L-13 S272A was
signiﬁcantly attenuated compared with control. Bcl2-L-13 S272A
showed less ability for binding with LC3 (Fig. 1e). Overexpression
of Bcl2-L-13 S272A induced mitochondrial fragmentation, but
decreased the LC3-II protein level and the number of LC3 dots
colocalized with ATP synthase (Fig. 8f–h). The amount of
processed mitochondrial targeted mCherry in Bcl2-L-13 S272A
overexpressing cells was less than that in cells transfected with
wild-type Bcl2-L-13 (Fig. 7c). Another possible mechanism to
regulate the function of Bcl2-L-13 will be ubiquitination. CCCP
induced ubiquitination of mitochondria in Parkin overexpressing
cells as previously reported26, but not in Bcl2-L-13 overexpressing
cells (Fig. 9), excluding the involvement of ubiquitination in the
regulation mechanism underlying the functions.
Discussion
Although Atg32 is essential for as mitophagy in yeast6,7,
no mammalian homologue has been identiﬁed. Here, we
demonstrate that Bcl2-L-13 is involved in mitophagy as well as
mitochondrial fragmentation. Most surprisingly, Bcl2-L-13
exhibited the ability to compensate the function of Atg32 in yeast.
In contrast to our results, Kataoka et al.15 reported that
overexpression of Bcl2-L-13 resulted in caspace-3 activation and
cytochrome c release from mitochondria in HEK293T cells. It has
been reported that Bcl2-L-13 shows no interaction with either
anti-apoptotic (Bcl-2, Bcl-xL, Bcl-w, A1, MCL-1, E1B-19K and
BHRF1) or pro-apoptotic (Bax, Bak, Bik, Bid, Bim and Bad)
members of the Bcl-2 family, even though it has BH1-4
domains15. Although we do not know the exact reason for the
discrepancy, some non-speciﬁc effects of its overexpression may
result in the induction of apoptosis.
Our results indicate that Bcl2-L-13 is localized to OMM and
interacts with LC3 through the conserved LIR sequence. In yeast,
Atg32 interacts with Atg8 and Atg11 (refs 6,7), suggesting Atg32
recruits Atg8 and Atg11 and they and other core Atg proteins
cooperatively generate isolation membranes surrounding
mitochondria. Interestingly, there is no known mammalian
homologue of Atg11 (ref. 27). Although the detailed mechanism
how Bcl2-L-13 mediates mitophagy is not entirely understood, we
can speculate that Bcl2-L-13 recruits LC3 to the surface of
mitochondria, leading to the formation of mitochondria-speciﬁc
autophagosomes (mitophagosomes). Bcl2-L-13 may bind to an
unidentiﬁed mammalian homologue of Atg11 or may play a role
as a scaffold in a similar fashion with Atg11.
Figure 4 | Drp1 is not essential for Bcl2-L-13-induced mitochondrial fragmentation. (a) HEK293A cells were transfected with Drp1-speciﬁc siRNA
(siDrp1) or with a non-targeting control siRNA (siCTRL), and after 48 h analysed by immunoblotting for Drp1. (b) Drp1 knockdown HEK293A cells were
transfected with empty vector or HA-Bcl2-L-13 for 48 h and then immunostained with the indicated antibodies along with MitoTracker Deep Red. Scale bar,
10mm. Boxed areas in the MitoTracker Deep Red images are shown at higher magniﬁcation (high) in right panels. (c) Transfected cells in (b) were scored
according to their mitochondrial morphology as fragmented, tubular or elongated patterns, and the percentages of distribution are shown in the bar graphs.
More than 80 cells were counted for each group (n¼ 3). Results are shown as the mean±s.e.m. *Po0.05 versus corresponding control group (Student’s
t-test). (d) Lysates from HEK293A cells transfected with empty vector, HA-Bcl2-L-13 or siBcl2-L-13 were subjected to immunoblotting with the indicated
antibodies. a-tubulin was used as a loading control. (e) HEK293A cell lysates expressing empty vector or HA-Bcl2-L-13 were subjected to SDS–gel
electrophoresis in the absence of 2-mercaptoethanol followed by immunoblotting with anti-Drp1 antibody. (f) HEK293A cell lysates expressing empty
vector or HA-Bcl2-L-13 were subjected to immunoblotting with the indicated antibodies targeted to proteins involved in mitochondrial fusion.
(g) Bak knockdown HEK293A cells were transfected with empty vector or HA-Bcl2-L-13 for 48 h and then immunostained with the indicated antibodies.
Scale bar, 10mm. Boxed areas in the ATP synthase staining are shown at higher magniﬁcation (high) in the right panels. (h) Bax knockdown HEK293A cells
were transfected with empty vector or HA-Bcl2-L-13 for 48 h and then immunostained with the indicated antibodies. Scale bar, 10mm. Boxed areas in the
ATP synthase staining are shown at higher magniﬁcation (high) in the right panels.
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Figure 5 | The role of LIR in Bcl2-L-13-induced mitophagy. (a) Immunoblots for LC3. HEK293A cells transfected with the indicated vectors were treated
with or without 20 nM of baﬁlomycin A1 for 1 h. The two blots from the top were originated from the same transfer membrane, but exposure time for the
second blot (short) was shorter than that for the top blot. Right upper and lower panels represent densitometric analysis of the ratio of LC3-II to GAPDH in
non-treated groups on the top blot and that in baﬁlomycin A1-treated groups on the second blot, respectively. The value for cells transfected with empty
vector in each experiment was set equal to 1 (n¼ 3). (b) mKeima expressing HEK293A cells were excited using 559 nm laser. Scale bar, 10 mm.
(c) Colocalization of autophagosomes and mitochondria in mKeima expressing cells transfected with GFP-LC3 and wild-type or LIR mutant HA-Bcl2-L-13.
Forty-eight h after transfection, cells were treated with E64d and pepstatin A for 4 h prior to analysis. Images in the box at higher magniﬁcation are shown
in the right panels. Scale bar, 10mm. (d) Colocalization of lysosomes and mitochondria in mKeima-expressing HEK293A cells transfected with the indicated
vectors for 48 h. Cells were stained with LysoTracker before microscopic analysis. Scale bar, 10mm. Images in the box at higher magniﬁcation are shown in
the right panels. (e) Quantiﬁcation of the number of LysoTracker-positive dots colocalized with mKeima in cells from (d). More than 60 cells were counted
for each group (n¼ 3). (f) Electron micrographs of autophagosomes engulﬁng mitochondria in an HEK293A cell transfected with HA-Bcl2-L-13. E64d and
pepstatin A were added 4 h before ﬁxation. Scale bar, 500nm. Right graph shows the number of mitophagic structures, which were counted in cell areas of
more than 0.165mm2 for each group (n¼ 3). (g) Mitochondrial DNA (mtDNA) normalized to nuclear DNA (nDNA) (n¼ 7). All quantitative results are
shown as the mean±s.e.m. *Po0.05 versus all other groups. A one-way ANOVA followed by Tukey–Kramer’s post hoc test was used for statistical
analysis.
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Mitophagy is closely linked to mitochondrial dynamics. Thus,
it is possible that Bcl2-L-13-induced mitophagy is a consequence
of mitochondrial fragmentation. However, our results showing
that the mutation in the LIR motif attenuated mitophagy without
affecting mitochondrial fragmentation and that Bcl2-L-13
induced mitophagy in Atg32-deﬁcient yeast strongly indicate
that Bcl2-L-13 has the dual effects. The molecular mechanisms of
Bcl2-L-13-mediated mitochondrial fragmentation remain to be
elucidated. Mitochondria exist largely as an extended, reticular
structure. For engulfment of mitochondria by isolation mem-
branes, the mitochondrial size will be an issue. In yeast, Atg11
recruits Dnm1 (a yeast homologue of Drp1), the ﬁssion
machinery to drive mitophagy, suggesting that Atg 11 plays a
role as a scaffold that recruits the ﬁssion components in addition
to its role in connecting the damaged mitochondria with the
autophagy machinery and mitochondrial fragmentation and
mitophagy occur in a coordinated manner4. Thus, the
mitochondria destined for degradation will be selected ﬁrst, and
then the ﬁssion machinery would be recruited to drive the
separation of these mitochondrial from the mitochondrial
network and ﬁnally the fragmented mitochondria are degraded
mediated through autophagy4. Since Bcl2-L-13 has the dual
effects, the coordination will operate more efﬁciently. We showed
that BH1-4 motifs are involved in Bcl2-L-13-induced
fragmentation. Identiﬁcation of a binding protein to the BH
domains in Bcl2-L-13 may elucidate a molecular mechanism
underlying the coordinated interaction between ﬁssion and
mitophagy.
CCCP is the most popular stimulus to induce mitochondrial
damage in cell biological research, which induces mitochondrial
fragmentation and mitophagy17, although the ability of CCCP to
induce mitophagy is not so potent as it decreases the total amount
of mitochondrial protein level in cells28 (Fig. 8d). We showed that
Bcl2-L-13 is essential for CCCP-induced mitochondrial
fragmentation and mitophagy, suggesting the physiological
importance of Bcl2-L-13. This leads to the question of how
Bcl2-L-13 is related to known pathways for mitochondrial
fragmentation and mitophagy. Our results indicate that Drp1 is
not essential for Bcl2-L-13-induced mitochondrial fragmentation.
However, we found the existence of elongated mitochondria and
reduced ratio of cells with fragmented mitochondria in Drp1
knockdown cells expressing Bcl2-L-13. These results suggest that
there may be some interaction between the two pathways. In
addition, we showed that Parkin is not necessary for Bcl2-L-13 to
induce mitophagy. The Parkin-deﬁcient mice have only modest
phenotypes14,29 and Parkin is not expressed in all cell types,
LysoTracker
LysoTracker
mKeima
mKeima
m
Ke
im
a
+
Bc
I2
-L
-1
3
Merge
Merge
Merge (high)
Merge (high)
si
CT
RL
+
ve
ct
or
si
CT
RL
+
Bc
I2
-L
-1
3
Ve
ct
or
Bc
I2
-L
-1
3
si
Pa
rk
in
+
ve
ct
or
si
Pa
rk
in
+
Bc
I2
-L
-1
3
Pa
rk
in
Tag Tom20 Merge
N
um
be
r o
f L
ys
oT
ra
ck
e
r 
do
ts
co
lo
ca
liz
e
d 
wi
th
 m
Ke
im
a 
pe
r c
el
l
siCTRL
siParkin
Vector
Bcl2-L-13
+
+
+
+
+
+
+ +– –
– –
–
–
–
–
20
15
10
5
0
*
*
a
b
c
m
Ke
im
a
+
ve
ct
or
Figure 6 | Bcl2-L-13-induced mitophagy is Parkin-independent. (a) Parkin knockdown in HEK293A cells stably expressing mKeima was achieved by
transfection with control siRNA (siCTRL) or Parkin-speciﬁc siRNA (siParkin). Then, the cells were transfected with empty vector or HA-Bcl2-L-13 and
stained with LysoTracker. Scale bar, 10mm. Images at higher magniﬁcation of areas in the box are shown in right panels. Right graph, quantiﬁcation of the
number of LysoTracker dots colocalized with mKeima. More than 30 cells were counted for each group (n¼ 3). Values represent the mean±s.e.m.
*Po0.05 versus siCTRL- or siParkin- and vector-transfected cells (A one-way ANOVA and Tukey–Kramer’s post hoc test). (b) HeLa cells transfected with
pMT-mKeima-Red and the indicated plasmids for 48 h were stained with LysoTracker. Scale bar, 10 mm. (c) Selective mitochondria elimination by Parkin or
Bcl2-L-13. HeLa cells expressing FLAG-Parkin or HA-Bcl2-L-13 were incubated with 10mM CCCP for 48 h. Cells were stained with DAPI and antibodies for
Tom20 and tag such as FLAG (Parkin) or HA (Bcl2-L-13). Outlines demarcate the edges of transfected cells. Scale bar, 10mm.
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suggesting the presence of alternate pathways of mitophagy. NIX
and FUNDC1 mediate mitophagy in mammalian cells8,9,30. These
are involved in speciﬁc types of mitophagy; the former for
mitochondrial elimination from reticulocytes, the latter for
hypoxia-induced mitophagy. However, we are not able to
exclude the possibility that Bcl2-L-13 can cooperate with NIX
and/or FUNDC1 for mitophagy. Germ-line gene ablation of Bcl2-
L-13 will provide its in vivo physiological role in mitochondrial
quality and quantity control.
The molecular mechanism underlying the activation of
Bcl2-L-13 to induce mitochondrial fragmentation and mitophagy
remains to be elucidated. The induction of the protein might
regulate mitochondrial fragmentation and/or mitophagy.
Furthermore, the Ser272 phosphorylation of Bcl2-L-13 regulates
mitophagy, but not mitochondrial fragmentation. When mito-
chondrial fragmentation is induced, unknown kinase(s) activates
the Bcl2-L-13 by phosphorylation of its Ser residue close to the
LIR domain to allow recruitment of mitophagy machinery.
Dysregulation of mitophagy is implicated in the development
of many chronic diseases including neurodegenerative diseases,
metabolic diseases and heart failure3. Our study will provide a
novel insight into molecular mechanisms of the pathogenesis of
such diseases.
Methods
Antibodies. Anti-Tim23 (1/1,000), anti-Tom20 (for western blots, 1/1,000, for
immunoﬂuorescence, 1/200), anti-Bcl2-L-13 (1/1,000) (Proteintech), anti-
cytochrome c (1/1,000) (BD biosciences), anti-Bcl2-L-13 (1/500), anti-GAPDH
(1/1,000), anti-Fis1 (1/1,000), anti-a-tubulin (1/1,000) (Abcam), anti-LC3B
(for western blots, 1/1,000, for immunoﬂuorescence, 1/100), anti-HA (for western
blots, 1/1,000, for immunoﬂuorescence, 1/200), anti-Drp1Ser637 (1/500),
anti-Drp1Ser616 (1/1,000), anti-Mfn2 (1/1,000), anti-cleaved caspase 3 (1/1,000)
(Cell Signaling Technology), anti-ATP synthase subunit beta (for western blots,
1/1,000, for immunoﬂuorescence, 1/200) (Life Technologies), anti-Drp1
(for western blots, 1/1,000, for immunoﬂuorescence, 1/100), anti-Opa1 (1/1,000)
(BD Transduction Laboratories), anti-FLAG (for immunoﬂuorescence, 1/200)
(Sigma), anti-Mfn1 (1/1,000) (Abnova), anti-ubiquitin (for immunoﬂuorescence,
1/200) (Enzo Life Science), anti-Phospho-Serine/Threonine (Upstate), anti-mCherry
(1/500) (Clontech) and anti-RFP23 (1/1,000) antibodies were used in this study.
Cell culture and transfection. HEK293A and HeLa cells were purchased from
ATCC. HEK293A cells were grown in Dulbecco’s modiﬁed Eagle’s medium
(Sigma) supplemented with 10% fetal bovine serum (Sigma) and 1% penicillin-
streptomycin (Life Technologies) at 37 C under 5% CO2. Transient transfections
were performed using Lipofectamine 2000 (Life Technologies) or ScreenFect A
(Wako) according to the manufacturer’s instructions. After 48 h of transfections,
cells were subjected to analysis, unless otherwise indicated. Mitophagy was induced
in HEK293A and HeLa cells by the treatment with 5 and 10 mM of CCCP for the
indicated time, respectively. Control cells were treated with the vehicle, dime-
thylsulphoxide (DMSO).
siRNA-mediated knockdown. Cells were transfected with siRNA for knockdown
of Parkin (30 nM stealth RNAi (Life Technologies)), Drp1 (20 nM BTsiMAX
(BONAC)), Bak (2.5 nM Silencer Select (Life Technologies)), Bax (25 nM
ON-TARGET plus (Dharmacon)) or Bcl2-L-13 (40 nM BTsiMAX) using
ScreenFect A or RNAiMax (Life Technologies). Non-targeting siRNA control was
obtained from BONAC. After 72 h of transfection, cells were subjected to analysis,
unless otherwise indicated.
Plasmid constructions. Constructs were obtained by conventional restriction
enzyme-based cloning. Site-directed mutagenesis was performed using the
QuikChange Site-Directed Mutagenesis Kit according to the supplier’s instructions
(Agilent Technologies).
cDNA encoding LC3B or Bcl2-L-13 was obtained by RT-PCR from C57B/6J
mouse heart total RNA with LC3B forward (50-GAATTCATGCCGTCCGAGA
AGACCTTC-30) and reverse (50-GAATTCGTCCGCTGGTAACATCCCTT-30)
primers, and Bcl2-L-13 forward (50-AGCAGAATTCATGGCGTCCTCTACGAC
TGC-30) and reverse (50-AGCAGAATTCTTACTTTCTTCTTAAAGCCAGT
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Figure 7 | Bcl2-L-13 can substitute for Atg32 to induce mitophagy. (a,b) Yeast transfected with wild-type or LIR mutant HA-Bcl2-L-13 or empty vector
were collected at the indicated time points after induction of mitophagy and subjected to western blotting for mCherry. The red arrows depict free mCherry
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GCA-30 , Rambo-R) primers, respectively. The ampliﬁed fragments were directly
inserted into pCR2.1-TOPO (Invitrogen) or pTA2 (Takara) and subcloned into
EcoR I site of pGBKT7 or pGADT7. pGADT7-Bcl2-L-13 W147A L150A, W273A
I276A, W147A L150A/W273A I276A were created by PCR-based site-directed
mutagenesis using pGADT7-Bcl2-L-13 as a template.
To obtain pGEX-LC3B fragment, mouse LC3B was ampliﬁed from pGBKT7-
LC3B with forward (50-AGCAGGATCCGCCGCCATCATGGAGGAGCAGAAG
CTG-30) and reverse (50-CTAGTTATGCGGCCGCTGCAGG-30) primers. The
ampliﬁed fragment was directly inserted into pCR2.1-TOPO and then subcloned
into EcoR I site of pGEX-6P-2.
pRS316-Atg32(1–388)-TAmito-3HA was previously described23. To obtain
p416GPD-Bcl2-L-13(1–407)-TAmito, a fragment of Bcl2-L-13(1–407) was
ampliﬁed from pGADT7-Bcl2-L-13 with forward (50-AGCAACTAGTGCCGCCA
TGGAGTACCCATACGACGTA-30 , Rambo-F) and reverse (50-AGCATCTAGAC
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Figure 8 | Physiological role of Bcl2-L-13 in mitochondrial homeostasis. (a,b) HEK293A cells transfected with siRNA were incubated with 5 mM CCCP for
4 h and stained with anti-ATP synthase antibody. Mitochondrial morphology was estimated in (b). More than 70 cells were counted for each group (n¼ 3).
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results are shown as the mean±s.e.m. Student’s t-test (c,d,e,h) or a one-way ANOVA followed by Tukey–Kramer’s post hoc test (b,f) was used for
statistical analysis.
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TTGCCCTCGGCGGGCAGGCCACT-30) primers. The ampliﬁed fragment was
directly inserted into pCR2.1-TOPO and then subcloned into pRS316-atg32
(1–388)-TAmito, in replacement for atg32(1–388). Finally Bcl2-L-13-TAmito
fragment was subcloned into p416GPD. To generate p416GPD-Bcl2-L-13 W273A
I276A (1–407)-TAmito, a fragment ﬂanking the LIR was obtained from
pcDNA3.1-Bcl2-L-13 W273A I276A by Sma I digestion and subcloned into the
corresponding site of p416GPD-Bcl2-L-13(1–407)-TAmito.
To obtain pcDNA3.1-HA-Bcl2-L-13, Bcl2-L-13 including HA tag was ampliﬁed
from pGADT7-Bcl2-L-13 with forward Rambo-F and reverse (50-AGCATCTAGA
CTTGCCCTCGGCGGGCAGGCCACT-30) primers. The ampliﬁed fragment was
subcloned into BamH I/Xho I site of pcDNA3.1. To obtain pcDNA3.1-HA-Bcl2-
L-13 DTM fragment, a stop codon after 408 Ala in Bcl2-L-13 was introduced by
PCR from pcDNA3.1-HA-Bcl2-L-13 with forward Rambo-F and reverse (50-AGC
ATCAGGCCTTGCCCTCGGCGGG CAGGCCACT-30) primers. The ampliﬁed
fragment was directly inserted into pCR2.1-TOPO and then subcloned into BamH
I/Xho I site of pcDNA3.1. To create pcDNA3.1-HA-Bcl2-L-13 DN(1–32),
a fragment of Bcl2-L-13 was obtained from pcDNA3.1-HA-Bcl2-L-13 with forward
(50-AGCAGAATTCATGGGTCCCTCACCCCCAGGAGTT-30) and reverse
Rambo-R primers. The ampliﬁed fragment was directly inserted into pCR2.1-TOPO
and subcloned into EcoR I site of pcDNA3.1-HA-Bcl2-L-13. To create pcDNA3.1-
HA-Bcl2-L-13 D142–154 and D192–228, N-terminal or C-terminal side of the
deletion site was ampliﬁed from pcDNA3.1-HA-Bcl2-L-13 with the following
primer pairs: D142–154N, forward (Rambo-F) and reverse (50-AGCACTGCAGT
CTCCACTGTACATTC-30) primers, D142–154 C: forward (50-AGCACTGCAGT
TTTGCTACAACACCTG-30) and reverse Rambo-R primers, D192–228N: forward
Rambo-F and reverse (50-AGCATCCGGAGATGAACTCTGCGGCGTGCTC-30)
primers, D192–228 C: forward (50-AGCATCCGGACAAGTTAGTCCCCCT-30)
and reverse Rambo-R primers. The ampliﬁed fragments were directly inserted into
pCR2.1-TOPO and subcloned into EcoR I site of pcDNA3.1-HA-Bcl2-L-13.
pcDNA3.1-HA-Bcl2-L-13 L101E, V19G and S272A were obtained by site-directed
mutagenesis of pcDNA3.1-HA-Bcl2-L-13. Parkin cDNA was created by PCR from
C57B/6 J mouse heart cDNA with Parkin forward (50-GCCCGGTGACCATGATA
GTG-30) and reverse (50-TTTCCCTTGAGGTTGTGCGT-30) primers. The
ampliﬁed fragments were directly inserted into pCR2.1-TOPO and cloned into Not
I/Xba I site of pCMV-FLAG4.
To obtain GFP-Bcl2-L-13, a fragment from pcDNA3.1-HA-Bcl2-L-13 was
cloned into BspE1 and Sal1 site of pEGFP-C1. To obtain pmCherry-Tom22, cDNA
encoding Tom22 was obtained by RT-PCR from C57B/6J mouse heart total RNA
with forward (50-TCCGGAATGGCCGCCGCCGTCGCTGCAGCC-30) and reverse
(50-CTACATCTTTCCAGGAAGTGGAGG-30) primers. The ampliﬁed fragments
were directly inserted into pCR2.1-TOPO and subcloned into BspE1 site of
pmCherry-C1 (Clontech).
All plasmid constructs were veriﬁed by restriction digestion and/or DNA
sequencing. pMT-mKeima-Red was purchased from MBL. pEGFP-LC3 was
obtained from Prof. Noboru Mizushima21.
Establishment of mKeima stable expression cell line. The pMT-mKeima-Red
plasmid was transfected into HEK293A cells using calcium phosphate method.
After 48 h, the cells were passaged and 1mgml 1 G418 for selection was added
24 h later. After 14 days, the single colonies were transferred to 24-well plates and
expanded.
Yeast two-hybrid assay. Bcl2-L-13 or its mutants containing W147A L150A or
W273A I276A substitution and LC3B were cloned into pGADT7 and pGBKT7,
respectively. The cloned constructs were co-introduced into AH109 yeast strain using
lithium acetate/polyethylene glycol with herring testis carrier DNA. The transfor-
mants were spotted on agar plates containing a synthetic dropout medium (Clontech)
lacking Leu and Trp for maintenance of the plasmids, and those additionally lacking
His and Ade to suppress background, and grown at 30 C for 4 days.
Mitophagy assay in yeast and mammalian cells. The cytosolic domain of
Bcl2-L-13 was fused in frame with a tail-anchor domain (amino acids 618–662)
of Gem1, an authentic mitochondrial outer membrane protein in yeast31.
p416GPD-Bcl2-L-13(1–407)-TAmito or the LIR mutant construct was introduced
into yeast strains expressing mitochondrial matrix-targeted DHFR-mCherry using
lithium acetate/polyethylene glycol with herring testis carrier DNA23. The
transformants were plated on SDCA-U (synthetic medium (0.17% yeast nitrogen
base without URA) containing 0.5% casamino acids and 2% dextrose) plate for 48 h
and streaked out onto the stock plate. For mitophagy induction, cells pregrown to
mid-log phase in SDCA-U medium were incubated at 30 C for 1–3 days in
synthetic medium containing 0.5% casamino acids and 0.1% dextrose plus 3%
glycerol (SGlyCA). Generation of free mCherry was detected by western blotting.
Yeast strains used are KOY1387 (his3D1 leu2D0 met15D0 ura3D0 TEFp-mito-
DHFR-mcherry::CgHIS3), KOY1422 (his3D1 leu2D0 met15D0 ura3D0 TEFp-mito-
DHFR-mcherry::CgHIS3 atg32::kanMX6) and KOY1424 (his3D1 leu2D0 met15D0
ura3D0 TEFp-mito-DHFR-mcherry::CgHIS3 atg7::kanMX6).
HEK293A cells were transfected with 250 ng of mCherry-Tom22 and 750 ng
of wild-type or the HA-Bcl2-L-13 mutants. Seventy-two h after transfection,
cells were lysed and subjected to western blotting for mCherry. Processed
mCherry-Tom22 was detected as 30 kDa protein band of free mCherry.
Live cell and immunoﬂuorescence microscopy. HEK293A cells stably expressing
mKeima were seeded at 5.0 104ml 1 in a glass-based dish (Iwaki) and trans-
fected 24 h later using ScreenFect A according to the manufacturer’s instructions.
The cells were imaged 48 h after transfection, otherwise indicated, by FV1000-D
(Olympus) equipped with cell culture incubator. To visualize the colocalization
of autophagosomes and mitochondria, cells transfected with pEGFP-LC3 and
Bcl2-L-13 constructs were treated with E64d (10mgml 1) and pepstatin A
(10 mgml 1) (Peptide Institute) for 4 h prior to analysis. We excited mKeima at
559 nm and collected the emission from 570 to 670 nm to monitor mitochondria.
For immunostaining, cells were plated on sterile coverslip (22mm diameter).
After treatment, cells were ﬁxed with 4% formaldehyde at 37 C for 10min,
permeabilized with 0.2% Triton X-100 for 15min, and then blocked with 2%
bovine serum albumin for 1 h at room temperature (RT). For immunostaining of
endogenous LC3, cells were ﬁxed and permeabilized with methanol for 10min at
 20 C. Cells were incubated with primary antibodies overnight at 4 C followed
by staining with secondary antibodies for 1 h at RT. After washing, cells were
mounted with Vectashield mounting medium (VECTOR Laboratories) and
analysed by LSM 510 (Zeiss) or FV1000-D.
To visualize the mitochondria or lysosomes, cells were stained with 100 nM
MitoTracker Deep Red FM (Molecular Probes), 100 nM MitoTracker Green or
50 nM LysoTracker Green (Molecular Probes) for 30min before confocal
microscopic analysis or ﬁxation. To evaluate mitochondrial membrane potential,
cells were stained with 100 nM TMRE (Molecular Probes) for 30min before
confocal microscopic analysis.
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Figure 9 | Ubiquitination is not involved in Bcl2-L-13-induced mitophagy.
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Electron microscopy. For electron microscopy, cells were ﬁrst ﬁxed with 2.5%
glutaraldehyde (Polysciences) at 37 C for 30min and then washed three times with
2.5% glutaraldehyde in 0.1M phosphate buffer (pH 7.4). For detecting mitophagy,
10mgml 1 pepstatin A and 10mgml 1 E64d were added 4 h before ﬁxation. The
samples were visualized using transmission electron microscope (Hitachi, H-7650)
at 80 kV.
SDS–PAGE and western blotting. Cells were rinsed in ice-cold PBS and lysed
in lysis buffer (50mM Tris-HCl, 137mM NaCl, 1mM EDTA, 10% glycerol,
1% Triton-X 100, a protease inhibitor cocktail (Roche), pH 8.0) on ice. Ten to 30 mg
of protein was subjected to SDS–polyacrylamide gel electrophoresis (SDS–PAGE)
and transferred to a nitrocellulose membrane. Membranes were incubated with
primary antibodies overnight at 4 C, followed by incubations with secondary
antibodies at RT for 1 h. Western blotting substrate plus (Pierce/Thermo Scientiﬁc)
or Lumigen ECL Ultra (Lumigen) was used to detect protein bands according
to the manufacturer’s instructions. NIH Image J software (version1.44p) or
ImageQuant TL (GE) was used for densitometric analyses. Images are cropped for
presentation. Uncropped images are presented in the Supplementary Material
(Supplementary Figs 1-4).
Immunoprecipitation. HEK293A cells were transfected for 48 h and lysed with
lysis buffer (50mM Tris-HCl, 137mM NaCl, 1mM EDTA, 10% glycerol,
1% Triton-X 100, a protease inhibitor cocktail, a phosphatase inhibitor cocktail
(Roche), pH 8.0). Lysates were incubated for 10min under rotation at 4 C,
followed by centrifugation at 15,000 g for 10min at 4 C. Lysates were precleared
with 20 ml of agarose-coupled protein A (GE healthcare) and 1 mg of rat
immunoglobulin G (Santa Cruz biochemistry). Precleared lysates were subjected to
immunoprecipitation using 200 ng of the anti-HA antibody (clone 3F10, Roche)
and 20ml of agarose-coupled protein A at 4 C for 2 h. The precipitate complexes
were washed three times with lysis buffer. Immunoprecipitates were then analysed
by immunoblotting.
For immunoprecipitation of endogenous Bcl2-L-13, cells were incubated with
20 nM baﬁlomycin A1 and DMSO or 5 mM CCCP for 1 h and collected with cold
PBS, then sonicated (200W, 90 s). After centrifugation at 700g for 5min at 4 C,
lysates were precleared with 40 ml of agarose-coupled protein A and 1 mg of rabbit
immunoglobulin G (Santa Cruz Biochemistry). Precleared lysates were subjected to
immunoprecipitation using 1 mg of the anti-Bcl2-L-13 antibody and 40 ml of
agarose-coupled protein A at 4 C for 2 h. The precipitate complexes were washed
three times with wash buffer (20mM Tris-HCl, 5mM NaCl, 2mM EGTA, 0.1%
Triton X-100, protease inhibitors, pH 7.4).
GST pulldown. GST fusion protein of LC3B was induced in Esherichia coli strain
BL21 (DE3) transfected with pGEX-LC3B by adding 1mM isopropyl-b-D-
thiogalactoside (Wako) for 3.5 h. Bacteria were lysed with PBS containing
1mgml 1 lysozyme (Wako), 30Uml 1 Benzonase (Sigma), 1mM dithiothreitol,
1mM EDTA, 1% Triton X-100 and protease inhibitors. GST-LC3B was puriﬁed on
Glutathione HiCap Matrix beads (Qiagen). For GST pulldown assay, HEK293A
cells were transfected with expression constructs encoding protein of interest using
Lipofectamine 2000, according to the manufacturer’s instructions. After 48 h, cells
were lysed in lysis buffer (50mM Tris-HCl, 137mM NaCl, 1mM EDTA, 10%
glycerol, 1% Triton-X 100, a protease inhibitor cocktail, pH 8.0) and the lysates
were incubated with 25 mg of GST-LC3B in 1ml of wash buffer (50mM Tris-HCl,
200mM NaCl, 1mM EDTA, 1% Igepal CA-630, 1mM dithiothreitol, 10mM
MgCl2, protease inhibitors, pH 8.0) for 2 h at 4 C and then washed ﬁve times with
1ml of wash buffer. The precipitate complex was boiled with 2 SDS–PAGE
loading buffer for 3min at 95 C and analysed by SDS-PAGE. The lower half of gel
was cut-off and stained with Coomassie Brilliant Blue (Wako) to visualize GST or
GST-LC3B and upper half was transferred to a nitrocellulose membrane and
immunoblotted with anti-HA antibody.
Subcellular fractionation. Subcellular fractionation of HEK293A cells was carried
out using a mitochondria isolation kit (Pierce/Thermo Scientiﬁc) according to the
manufacturer’s instructions. For proteinase K digestion, mitochondria fraction was
suspended in MB buffer (210mM mannitol, 70mM sucrose, 10mM HEPES, 1mM
EDTA, pH 7.5) with 50mgml 1 proteinase K (Wako) and incubated for 30min at
RT. For analysis of membrane proteins, mitochondrial pellets were resuspended in
100ml of MB buffer or MB buffer containing 0.1M Na2CO3 (pH 11.5) and incu-
bated on ice for 30min19.
Mitochondrial DNA quantiﬁcation. DNA from HEK293A cells was extracted
using the QIAamp DNA Mini Kit (Qiagen) according to the manufacturer’s
instructions. The SyBR GreenER qPCR SuperMix (Invitrogen) was used for
quantitative PCR with an ABI PRISM 7900HT sequence detection system (Applied
Biosystems). The Human Mitochondrial DNA (mtDNA) Monitoring Primer Set
(Takara) was used for ampliﬁcation of mtDNA and nuclear DNA (nDNA), and
data analysis was performed according to the manufacturer’s instructions.
Statistical analysis. Results are shown as the mean±s.e.m. Paired data were
evaluated by Student’s t-test. A one-way analysis of variance (ANOVA) followed by
Tukey–Kramer’s post hoc test was used for multiple comparisons. A value of
Po0.05 was considered statistically signiﬁcant.
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